Inixaciclib
Inixaciclib is a potent CDK inhibitor, can be used to research anticancer.
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/inixaciclib.html
Purity
99.93
Solubility
DMSO : 11.9 mg/mL (ultrasonic; warming; adjust pH to 3 with HCl; heat to 60°C)
Smiles
CN1CCC(C2=CN=C(NC3=NC=C(F)C(C4=CC(F)=C(OCCN5C(C)C)C5=C4)=N3)C=C2)CC1
Molecular Formula
C26H30F2N6O
Molecular Weight
480.55
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-45661/Inixaciclib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-45661/Inixaciclib-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2370913-42-9]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CSB-EP815575HU-01 20 µg
Recombinant Human Poly [ADP-ribose] polymerase 9 (PARP9), partial
Ask
View Details CSB-EP815575HU-02 100 µg
Recombinant Human Poly [ADP-ribose] polymerase 9 (PARP9), partial
Ask
View Details CSB-EP815575HU-03 1 mg
Recombinant Human Poly [ADP-ribose] polymerase 9 (PARP9), partial
Ask
View Details